# Vedana Therapeutics

**Canonical:** https://apis.io/providers/vedana-therapeutics/  
**Website:** https://vedanatx.com/  
**APIs profiled:** 0

Vedana Therapeutics is a clinical-stage biotechnology company developing next-generation medicines for migraine prevention. Founded by biotech investor Anurag Agarwal and antibody-development veteran Leon Garcia, the company emerged from stealth in June 2026 with a $46 million Series A co-led by Westlake BioPartners and Canaan Partners, with participation from Dawn Biopharma and Alexandria Venture Investments. Vedana is building a portfolio of long-acting, subcutaneously dosed monoclonal antibodies that go beyond CGRP by targeting PACAP (pituitary adenylate cyclase-activating peptide) and other CGRP-independent pathways, aiming to deliver complete and lasting relief for the majority of migraine patients who remain suboptimally controlled on current standard of care. Its preclinical pipeline includes VDN-0100 (anti-PACAP antibody, first-in-human planned 2027), VDN-0200 (PACAP x CGRP bispecific), and two undisclosed programs. This profile was surfaced as a portfolio company of Canaan Partners and added to the API Evangelist network. Vedana is a therapeutics company and publishes no public API or developer surface; this record captures its corporate identity for discovery.

## Kin Score — 8.3 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 8.3).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Vedana Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Therapeutics, Pharmaceuticals, Neuroscience, Migraine, Antibodies, Drug Discovery, Life Sciences, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/vedana-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.